What happenedRaised $35M.
The company said the funding supports advance its ProFoundry platform and agentic AI capabilities to discover novel biomarkers, protein drugs, and drug targets for preeclampsia and eclampsia Led by CEO John Lepore, ProFound Therapeutics is a biotechnology company focused on uncovering new protein drugs and drug targets hidden within the expanded human proteome.
What nextadvance its ProFoundry platform and agentic AI capabilities to discover novel biomarkers, protein drugs, and drug targets for preeclampsia and eclampsia Led by CEO John Lepore, ProFound Therapeutics is a biotechnology company focused on uncovering new protein drugs and drug targets hidden within the expanded human proteome.
Where you helpLocal market experienceEmployment infrastructureLegal and tax setupProduct leadership
Approach preferences not yet specified